ROME Therapeutics Debuts First Preclinical Data of its LINE-1 Reverse Transcriptase Inhibitors in Neurodegenerative Diseases at 3rd Annual Dark Genome Symposium

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    ENP Newswire. November 22, 2024